Videos
Case Review: Progression in Follicular Lymphoma
Thomas W. Flaig, MD, discusses the most dramatic change in the treatment landscape for patients with advanced bladder cancer. Over the last several years, 5 checkpoint inhibitors have been approved in this space.
John H. Ward, MD, discusses the role of 21-gene assays in selecting patients with breast cancer for adjuvant chemotherapy treatment.
Carla Casulo, MD, discusses the challenges surrounding the treatment of patients with relapsed/refractory follicular lymphoma.
A 58-Year-Old Woman with Polycythemia Vera
Ahmed Omar Kaseb, MD, associate professor of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center, says 2 major challenges in hepatocellular carcinoma are the lack of effective treatments and the co-existing underlying chronic liver disease.
A Case of HR+ Metastatic Breast Cancer
JAK Inhibition for the Management of Primary Myelofibrosis